Text Size
Overview | Description | Applications | Operations | Results | Publications | Images
Experiment/Payload OverviewNeuroendocrine and Immune Responses in Humans During and After Long Term Stay at ISS (Immuno) will provide an understanding for the development of pharmacological tools to counter unwanted immunological side effects during long-duration missions in space.
Principal InvestigatorGerman Aerospace Center, Cologne, Germany
Sponsoring AgencyEuropean Space Agency (ESA)
Expeditions Assigned|14|15|16|18|19|20|
Previous ISS MissionsInformation Pending
Immuno will determine neuroendocrine and immunological changes during and after working and living on the ISS. A focus on cellular energy metabolism and cell signaling will provide additional information on the psycho-neuroendocrine and immunologic adaptation of human physiology to space and a better insight on how these processes are dependent on the cellular level of signal processing.
Immuno aims to provide the understanding for the development of pharmacological tools to countermeasure unwanted immunological side effects during long-duration missions into space.
Earth ApplicationsThe Immuno investigation will provide insight into the disease process of immunocompromised humans on Earth.
Immuno will involve taking several preflight and inflight measurements. A Current Stress Test (CST), paper stress test designed to repeatedly determine an individuals? psychological state under the conditions of acute and chronic stress, is taken. A urine collection will be performed for determination of dopamine or epinephrine in urine collected within 24 hours. A saliva collection will be performed in the morning and in the evening by chewing on a cotton swab for 30-45 seconds. Fluid will then be removed from the swab by centrifugation and kept frozen at -20 degrees C. Blood collections will also be performed to analyze the blood and blood components. This experiment is planned to be carried out over multiple ISS Increment crews, requiring six subjects in total.
Operational ProtocolsA preflight test will be conducted between launch minus 30 days (L-30) and launch minus 7 days (L-7). Two inflight sample collections will occur; the first between launch plus 30 days (L+30) and launch plus 90 days (L+90). The second inflight sample collection will occur between launch plus 150 days (L+150) and return minus 14 days (R-14).
Information Pending
Blood sample showing white blood cells: Lymphocytes (L) and Granulocytes (G). Image courtesy of ESA.